Semaglutide (marketed as 'Ozempic' and 'Wegovy') and the dual-agonist Tirzepatide ('Mounjaro' and 'Zepbound') are some of today's most talked-about medications, given their unprecedented clinical efficacies across both weight loss and T2D management
The table below compares 2026 pricing across the main options
CADTH is not responsible for any errors, omissions, injury, loss, or damage arising from or relating to the use (or misuse) of any information, statements, or conclusions contained in or implied by the contents of this document or any of the source materials
This material is not intended for human or animal use, and it is not a drug, supplement, diagnostic, or therapeutic product
Log shots, set injection reminders, track side effects, watch your weight loss trends, and stay on course, even after you reach your goal